|
|
Volumn 1, Issue 5, 2009, Pages 394-416
|
|
Part 1: Proceedings of the European Medicines Agency workshop on biosimilar monoclonal antibodies
a
c
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ABSEAMED;
BASILIXIMAB;
BEVACIZUMAB;
BINOCRIT;
CALCITONIN;
CLOTINAB;
DOXORUBICIN;
EPOETIN ALFA HEXAL;
FILGRASTIM HEXAL;
FILGRASTIM RATIOPHARM;
FILGRASTIM ZARZIO;
GLUCAGON;
HUMAN GROWTH HORMONE;
HYALURONIDASE;
HYLENEX;
IMMUNOGLOBULIN F(AB) FRAGMENT;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
OMALIZUMAB;
PALIVIZUMAB;
RATIOGRASTIM;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GLUCAGON;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RETACRIT;
SALCATONIN;
SILAPO;
TEVAGRASTIM;
UNCLASSIFIED DRUG;
BIOLOGICAL PRODUCT;
DRUG;
CONFERENCE PAPER;
DNA SEQUENCE;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG POTENCY;
DRUG SAFETY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
IMMUNOGENICITY;
MEDICAL SOCIETY;
PHYSICAL CHEMISTRY;
PRACTICE GUIDELINE;
ANIMAL;
ASIA;
BIOTECHNOLOGY;
CATTLE;
DRUG APPROVAL;
EUROPE;
GOVERNMENT REGULATION;
HUMAN;
LEGAL ASPECT;
METHODOLOGY;
PHARMACOKINETICS;
STANDARD;
UNITED STATES;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ASIA;
BIOLOGICAL PRODUCTS;
BIOTECHNOLOGY;
CATTLE;
DRUG APPROVAL;
DRUG INDUSTRY;
EUROPE;
GOVERNMENT REGULATION;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
THERAPEUTIC EQUIVALENCY;
UNITED STATES;
|
|
EID: 77950360464
PISSN: 19420862
EISSN: None
Source Type: Journal
DOI: 10.4161/mabs.1.5.9630 Document Type: Conference Paper |
|
Times cited : (43)
|
|
References (10)
|
